Molecular Mechanisms of Developmental and Tumor Angiogenesis

Brain Pathology - Tập 4 Số 3 - Trang 207-218 - 1994
Karl H. Plate1,2, Georg Breier1, Werner Risau1
1Abteilung Molekulare Zellbiologie, Max-Planck Institut für physiologische und klinische Forschung, W. G. Kerckhoff-Institut, 61231 Bad Nauheim, Germany
2Abteilung Neuropathologie, Klinikum der Philipps-Universität, 35043 Marburg, Germany

Tóm tắt

Angiogenesis, the sprouting of capillaries from preexisting vessels, is of fundamental importance during embryonic development and is the principal process by which the brain and certain other organs become vascularized. Angiogenesis occurs during embryonic development but is almost absent in adult tissues. Transient and tightly controlled (physiological) angiogenesis in adult tissues occurs during the female reproductive cycle and during wound healing. In contrast, pathological angiogenesis is characterized by the persistent proliferation of endothelial cells, and is a prominent feature of diseases such as proliferative retinopathy, rheumathoid arthritis, and psoriasis. In addition, many tumors are able to attract blood vessels from neighbouring tissues. Tumor‐induced angiogenesis requires a constitutive activation of endothelial cells. These endothelial cells dissolve their surrounding extracellular matrix, migrate toward the tumor, proliferate, and form a new vascular network, thus supplying the tumor with nutrients and oxygen and removing waste products. The onset of angiogenesis in human gliomas is characterized by the expression of genes encoding angiogenic growth factors such as vascular endothelial growth factor (VEGF), platelet‐derived growth factor (PDGF) in tumor cells, and coordinate induction of genes in endothelial cells which encode the respective growth factor receptors. Developmental and tumor angiogenesis appear to be regulated by a paracrine mechanism involving VEGF and VEGF receptor‐1 and ‐2.

Từ khóa


Tài liệu tham khảo

Russel DS, 1989, Pathology of tumours of the nervous system

10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X

James CD, 1988, Clonal genomic alterations in glioma malignancy stages, Cancer Res, 48, 5546

10.1002/jcb.240460103

10.1038/355846a0

10.1038/313144a0

10.1002/1097-0142(195803/04)11:2<264::AID-CNCR2820110207>3.0.CO;2-D

McComb RD, 1984, The biology of malignant gliomas ‐ a comprehensive survey, Clin Neuropathol, 3, 93

10.1097/00005072-199211000-00008

10.1007/BF01889141

10.1007/978-3-642-84988-6

10.3171/jns.1989.70.5.0701

10.1093/jnci/82.1.4

Folkman J, 1993, Cancer Medicine

Folkman J, 1991, Origins of human cancer: A comprehensive review, 803

10.1038/315115a0

10.1016/0092-8674(91)90033-U

10.1038/339058a0

10.1126/science.2432664

10.1016/0955-2235(90)90010-H

Risau W, 1992, Metastasis: Basic research and its clinical applications, 224, 10.1159/000421805

10.1016/S0021-9258(19)49853-0

10.1073/pnas.83.8.2448

10.1073/pnas.87.15.5710

10.1007/BF00308718

Maxwell M, 1991, Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression, Cancer Res, 51, 1345

Stefanik DF, 1991, Acidic and basic fibroblast growth factor are present in glioblastoma multiforme, Cancer Res, 51, 5760

Zagzag D, 1990, Immunohistochemical localization of basic fibroblast growth factor in astrocytomas, Cancer Res, 50, 7393

10.1073/pnas.85.20.7748

Hermanson M, 1992, Platelet‐derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops, Cancer Res, 52, 3313

10.1172/JCI114675

Schnürch H, 1991, Differentiating and mature neurons express the acidic fibroblast growth factor gene during chick neural development, Development, 111, 1143, 10.1242/dev.111.4.1143

Wanaka A, 1991, Expression of FGF receptor gene in rat development, Development, 111, 455, 10.1242/dev.111.2.455

Peters KG, 1992, Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissue during limb formation and organogenesis in the mouse, Development, 114, 233, 10.1242/dev.114.1.233

10.1016/0014-5793(91)81004-R

10.1093/jnci/85.2.121

10.1002/j.1460-2075.1992.tb05523.x

10.1073/pnas.88.5.2021

10.3109/08977199209046408

Holmgren L, 1991, Angiogenesis during extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression, Development, 113, 749, 10.1242/dev.113.3.749

Reuterdahl C, 1991, Characterization of platelet‐derived growth factor ß‐receptor expressing cells in the vasculature of human rheumathoid synovium, Lab Invest, 64, 321

Plate KH, 1992, Platelet‐derived growth factor receptor‐ß is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas, Lab Invest, 67, 529

Sato N, 1993, Platelet‐derived growth factor indirectly stimulates angiogenesis in vitro, AmJPathon, 42, 1119

10.1016/S0021-9258(18)99049-6

10.3109/08977199109000278

10.1097/00005072-199209000-00002

10.1016/0006-291X(86)91209-X

10.1016/S0006-291X(05)81572-4

10.1038/329630a0

10.1073/pnas.84.15.5277

10.1126/science.1281554

10.1210/edrv-13-1-18

10.1016/0960-9822(93)90073-W

10.1242/dev.114.2.521

10.1016/0092-8674(93)90573-9

10.1038/359843a0

Plate KH, 1993, Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis, Cancer Res, 53, 5822

10.1006/bbrc.1993.2144

10.1038/359845a0

Brown LF, 1993, Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas, Am J Pathol, 143, 1255

10.1038/367576a0

10.1172/JCI116450

Cullinan‐Bove K, 1993, Vascular endothelial growth factor / vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen‐induced increase in uterine capillary permeability and growth, Endocrinology, 133, 829, 10.1210/endo.133.2.8344219

10.1095/biolreprod48.5.1120

10.1126/science.6823562

10.1126/science.2479987

10.1126/science.2479986

10.1073/pnas.87.7.2628

10.1016/0006-291X(91)91276-I

10.1002/jcp.1041530317

Ferrara N, 1989, Pituitary follicular cells secrete a novel heparin ‐binding growth factor specific for vascular endothelial cells, Biochem Biophys Res Comm, 161, 851, 10.1016/0006-291X(89)92678-8

10.1073/pnas.87.4.1323

10.1016/S0006-291X(05)80313-4

10.1210/mend-5-12-1806

10.1016/S0021-9258(18)35712-0

10.1091/mbc.4.12.1317

10.1073/pnas.88.20.9267

10.1172/JCI116165

DvorakHF SioussatTM BrownLF BerseB NagyJA SotrelA ManseauEJ Van de WaterL SengerDR(1991)Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.J Exp Med MA:1275–1278.

Shibuya M, 1990, Nucleotide sequence and expression of a novel human receptor‐type tyrosine kinase (fit) closely related to the fms family, Oncogene, 5, 519

10.1126/science.1312256

10.1073/pnas.90.16.7533

10.1016/0006-291X(92)90483-2

10.1016/0092-8674(90)90801-K

10.1172/JCI115568

10.1006/bbrc.1993.1106

10.1002/jcb.240540107

Phillips HS, 1993, Intense focal expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: association with regions of necrosis, Int J Oncol, 2, 913

10.1002/ijc.2910310104

10.1016/S0021-9258(17)41787-X

10.1016/S0006-291X(05)81103-9

Claffey KP, 1992, Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways, J BiolChem, 267, 16317

Pertovaara L, 1994, Vascular endothelial growth factor is induced in response to transforming growth factor‐ß in fibroblastic and epithelial cells, J Biol Chem, 269, 6271, 10.1016/S0021-9258(17)37365-9

10.1091/mbc.4.1.121

Kieser A, 1994, Mutant p53 potentiates protein kinase c induction of vascular endothelial growth factor expression, Oncogene, 9, 963

Risau W, 1991, The development of the vascular system, 58

10.1007/978-3-642-67432-7_1

10.1016/0165-3806(85)90044-6

10.1073/pnas.83.11.3855

Risau W, 1987, Endothelial cell growth factors in embryonic and adult chick brain are related to human acidic fibroblast growth factor, EMBO J, 7, 959, 10.1002/j.1460-2075.1988.tb02901.x

10.1210/endo.133.2.7688292

Oelrichs RB, 1993, NYK/FLK‐1: a putative receptor tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo, Oncogene, 8, 11

Yamaguchi TP, 1993, flk‐1, an flt‐1 related receptor tyrosine kinase is an early marker for endothelial cell precursors, Deve/opment, 118, 489

10.1128/MCB.12.4.1698

Dumont DJ, 1992, tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors, Oncogene, 7, 1471

10.1242/dev.119.3.957

10.1073/pnas.90.20.9355

Maisonpierre PC, 1993, Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family, Oncogene, 8, 1631

10.1056/NEJM197111182852108

10.1056/NEJM199101033240101

10.1093/jnci/84.24.1875

Weidner N, 1993, Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma, Am J Pathol, 143, 401

Barnhill RL, 1992, Angiogenesis and tumor progression of melanoma, Lab Invest, 67, 331

Folkman J, 1991, Biological therapy of cancer

10.1038/nbt0791-630

Brem S, 1972, Tumor angiogenesis: a quantitative method for histological grading, J Natl Cancer Inst, 48, 347

10.1038/362841a0

10.1006/bbrc.1993.1955